chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test negative, No therapeutic response
Clinical narrative: Information has been received from a physician concerning her "approximately 2 year old" son who on an unspecified date was vaccinated with MMR II vaccine (Merck). It was noted that the patient was given a titer test after receiving the vaccination, and the test concluded that the child did not respond to one of the components (component not identified). Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTP, MMR, OPV
Symptoms: Blood immunoglobulin G decreased, Hepatitis B antibody, Mumps antibody test negative, No therapeutic response
Clinical narrative: Information has been received from a licensed practical nurse concerning a male patient with sulfa eye drop hypersensitivity and a history of migraine, allergies, and sleep disorder who was vaccinated SQ with a 0.5 mL dose of MMR II in 1998 and in 1991. Concomitant therapy included nortriptyline and IMITREX. Subsequently a laboratory test showed that the patient had a low titer for mumps. The patient sought medical attention at the physician's office. The patient's low titer for mumps persisted. No product quality complaint was involved. Follow-up information was received from a licensed practical nurse on 15-JUL-2008, indicating that, on 19-JUN-2008, the patient received a third dose of MMR II (Lot number 660207/0453X). The patient had two doses of MMR II given at a pediatrician's office. Also, the date of the first dose was changed from 1991 (month unknown) to 01-AUG-1991 (day unknown). It was also noted that the patient received "DPT" vaccine and also "OPV" vaccine on 27-OCT-1988 and in August 1991. Diagnostics on 02-JUN-2008: Mumps Virus IgG AB - 0.97 (values between 0.91 and 1.09 are considered "equivocal" low). Also, an Anti-HB's Titer was done (date in question, reported as "3/13/10") but results not reported. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a health professional concerning an adult patient who was vaccinated with MMR II as a child and had a negative titer in the Fall of 2007.  The patient was vaccinated subcutaneously with a 0.5 ml booster dose of MMR II 0.5 ml in the fall of 2007.  A titer was redrawn in December 2007, and the patient remained negative for rubella.  No additional information is available.
Sex: U
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a health professional concerning an adult patient who was vaccinated with MMR II vaccine as a child and had a negative titer in the Fall of 2007. The patient was vaccinated subcutaneously with a 0.5 ml booster dose of MMR II 0.5 ml in the fall of 2007. A titer was redrawn in December 2007, and the patient remained negative for rubella. No additional information is available.
Sex: U
Vaccine: MMR
Symptoms: Incorrect route of drug administration, Injection site discomfort
Clinical narrative: Information has been received from a registered nurse concerning a patient who on 17-JUN-2008 was vaccinated IM instead of SC with a dose of MMR II (lot# unknown). No adverse event was reported. No product quality complaint was involved. Additional information has been requested. Follow-up information was received from the registered nurse concerning the patient with no illness at the time of vaccination who was vaccinated with a dose of MMR II previously reported on 17-JUN-2008. However, it was noted that, on 16-JUN-2008 at 2:00 PM, the patient experienced mild discomfort at the site. No vaccines were given within four weeks of vaccination and no diagnostic studies were performed. No additional information is available.
Age: 1.17
Sex: F
Vaccine: MMR
Symptoms: Measles antibody positive, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a physician concerning a 4 year old female patient who was vaccinated with a dose of MMR II at 16 months of age. Antibody titers were drawn "recently" and the mumps titer was "low." The measles and rubella titers were adequate. The exact antibody titer results were not provided. The patient sought medical attention at the physician's office. No product quality complaint was involved. Additional information has been requested.
Age: 1.7
Sex: F
Vaccine: MMR
Symptoms: Blood test, Body temperature increased, Conjunctivitis, Eye discharge, Ocular hyperaemia
Clinical narrative: Information has been received from a medical assistant concerning a 21 month old female child with no known allergies, or pertinent medical history who on 10-JUN-2008 was vaccinated SQ with 0.5ml of MMR II (Lot # 660208/0454X). There was no concomitant medication. Subsequently, on 23-JUN-2008 the patient was seen back in the office for a fever and a rash. It was noted that the rash started on the patient's legs and spread upwards onto her body. The patient's mother reported the patient had a fever as high as 103.0 degrees F. The patient's eyes were also red with a discharge. There was no itching noted. It was also reported that the patient had a low grade temperature at the physician's office. "Blood work" was obtained. The results showed "no measles, probably a reaction to the vaccine." At the time of the report the patient was recovering. There was no product quality complaint involved. Follow-up information has been received from a medical assistant concerning this 21 month old female patient who, on 13-JUN-2008, was vaccinated S.Q. in the left deltoid with a first dose of MMR II (lot # 660208/0454X). The patient had otitis media and an upper respiratory tract infection at the time of vaccination. On 23-JUN-2008 the patient developed a measles-like rash, fever and conjunctivitis 13 days after vaccination. It was noted that the patient was on amoxicillin at the time (day 9 of 10) of vaccination for otitis media. Subsequently, the patient recovered on 25-JUN-2008. Additional information is not expected.
Age: 1.7
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash morbilliform
Clinical narrative: Information has been received from a medical assistant concerning a 21 month old female child with no known allergies, or pertinent medical history who on 10-JUN-2008 was vaccinated SQ with 0.5ml of MMR II (Lot # 660208/0454X). There was no concomitant medication. Subsequently, on 23-JUN-2008 the patient was seen back in the office for a fever and a rash. It was noted that the rash started on the patient's legs and spread upwards onto her body. The patient's mother reported the patient had a fever as high as 103.0 degrees F. The patient's eyes were also red with a discharge. There was no itching noted. It was also reported that the patient had a low grade temperature at the physician's office. "Blood work" was obtained. The results showed "no measles, probably a reaction to the vaccine." At the time of the report the patient was recovering. There was no product quality complaint involved. Follow-up information has been received from a medical assistant concerning this 21 month old female patient who, on 13-JUN-2008, was vaccinated S.Q. in the left deltoid with a first dose of MMR II (lot # 660208/0454X). The patient had otitis media and an upper respiratory tract infection at the time of vaccination. On 23-JUN-2008 the patient developed a measles-like rash, fever and conjunctivitis 13 days after vaccination. It was noted that the patient was on amoxicillin at the time (day 9 of 10) of vaccination for otitis media. Subsequently, the patient recovered on 25-JUN-2008. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from an office manager concerning a 12 month old male child with no known allergies, benign heart murmur and eczema who on 10-JUN-2008 at 11:15 hour was vaccinated SQ "right" with a first dose of MMR II (lot # 655486/0426U) (rHA).  There was no concomitant medication.  Subsequently, on 14-JUN-2008 (previously reported as 15-JUN-2008) the patient experienced 3 days of fever of 103 F and then on 19-JUN-2008 the patient developed (broke out in) a rash.  Medical attention was sought.  On 19-JUN-2008 the patient was seen in the office.  There were no lab studies performed.  At the time of the report the patient recovered from the rash on an unspecified date.  There was no product quality complaint involved.  Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: A caller reported that her daughter experienced fever about 7 days after vaccination with her first dose of MMR II, injection, when the child was 3 and a half years old that lasted about a day and a half.  The patient at 3 months old picked up a "lung virus" after being vaccinated with a couple of vaccines (vaccines unspecified).  No further information provided.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a physician concerning a 19 year old female with penicillin allergy and AUGMENTIN allergy who had two doses of MMR II in 1990 and 1992. There was no concomitant medication. It was reported the patient had a low titer for mumps. It was reported that the patient's present status has not improved. No product quality complaint. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: MMR
Symptoms: Eye infection, Incorrect route of drug administration, Injection site nodule, Measles post vaccine, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 13 month old female old female with port wine naevus and sensitivity to OMNICEF who on 23-JUN-2008 was vaccinated with MMR II, IM. Concomitant therapy included "unknown other vaccination" (therapy unspecified). On 23-JUN-2008 the patient developed a golf ball size knot at the injection site. She was treated with ice packs and TYLENOL. Ten days after vaccination the patient developed a rash all over her body and a slight fever. The rash was diagnosed as measles. The patient also developed an eye infection which is being treated with unknown eye drops. It is reported that the patient is recovering from the events. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: Information has been received from a physician concerning a 13 month old female old female with port wine naevus and sensitivity to OMNICEF who on 23-JUN-2008 was vaccinated with MMR II, IM. Concomitant therapy included "unknown other vaccination" (therapy unspecified). On 23-JUN-2008 the patient developed a golf ball size knot at the injection site. She was treated with ice packs and TYLENOL. Ten days after vaccination the patient developed a rash all over her body and a slight fever. The rash was diagnosed as measles. The patient also developed an eye infection which is being treated with unknown eye drops. It is reported that the patient is recovering from the events. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a nurse practitioner concerning a 4 year old female with a history of eczema who on 04-SEP-2004 was vaccinated with MMR II, 0.5 ml SQ.  It was reported that the patient had a negative titer for mumps.  The patient did not seek medical attention.  No product quality complaint.  Additional information has been received from a nurse practitioner indicating that the 5 year old female patient did not get immunity to mumps and is allergic to eggs so she was unable to obtain a second dose.  Additional information is not expected.
Age: 10.0
Sex: F
Vaccine: MMR
Symptoms: Hepatitis B antibody positive, Rubella antibody negative
Clinical narrative: Information has been received from a health professional and healthcare worker concerning a 21 year old female who on 01-NOV-1996 was vaccinated with her second dose of MMR II (lot# 618617/0734D). On 10-JUL-2008 the patient was vaccinated with a third dose of MMR II (lot# reported as "1310D"). There was no concomitant medication. Subsequently the patient experienced no rubella antibodies detected after the third dose. The first dose of MMR II was administered at another office and the nurse did not have the date of administration. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Blood albumin decreased, Epstein-Barr virus test positive, Infectious mononucleosis, Lymphocyte morphology abnormal, Mean cell haemoglobin concentration decreased
Clinical narrative: Information has been received from a physician concerning a female patient with an "autoimmune disease" who on an unspecified date was vaccinated with MMR II. Subsequently, "last winter" in approximately 2007 the patient developed mumps after receiving the vaccination. Medical attention was sought. The patient was seen by the physician. It was unspecified if lab studies were performed. At the time of report the patient recovered on an unspecified date. There was no product quality complaint involved. Follow-up information has been received from a registered nurse and medical records dated 20-FEB-2008 concerning a 14 year old white female patient with colitis ulcerative who on 05-JAN-1998 was vaccinated S.Q. with a second dose of MMR II (lot # 622896/0740E). In February 2008, the patient developed acute mumps parotitis. Medical attention was sought. On 20-FEB-2008 the patient had lab studies performed which revealed the following abnormal results: albumin 3.3 L (3.4-5.0 G/DL), MCHC 32.8 L (33.4-35.9 G/DL), RDW 17.0 H (11.5-14.5 %), metamyelocyte 1 H (0 %), atypical lymph 6 H (0-5 %), sed rate 44 H (0-20 MM/HR), mononucleosis test positive (negative), mumps viral AB 4.70 (>= 1.10 positive: IgG antibody to mumps detected which may indicate current or previous exposure/immunization to mumps), mumps IgM antibody 4.74 (greater than 1.20 index: positive). At the time of the report, the patient recovered on an unspecified date. Follow-up information was received from a medical assistant (M.A.) in the physician's office via phone call. The M.A. confirmed that the patient was not hospitalized from 20-FEB-2008 to 25-FEB-2008. Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Metamyelocyte count increased, Mumps, Mumps antibody test positive, Parotitis, Red blood cell sedimentation rate increased
Clinical narrative: Information has been received from a physician concerning a female patient with an "autoimmune disease" who on an unspecified date was vaccinated with MMR II. Subsequently, "last winter" in approximately 2007 the patient developed mumps after receiving the vaccination. Medical attention was sought. The patient was seen by the physician. It was unspecified if lab studies were performed. At the time of report the patient recovered on an unspecified date. There was no product quality complaint involved. Follow-up information has been received from a registered nurse and medical records dated 20-FEB-2008 concerning a 14 year old white female patient with colitis ulcerative who on 05-JAN-1998 was vaccinated S.Q. with a second dose of MMR II (lot # 622896/0740E). In February 2008, the patient developed acute mumps parotitis. Medical attention was sought. On 20-FEB-2008 the patient had lab studies performed which revealed the following abnormal results: albumin 3.3 L (3.4-5.0 G/DL), MCHC 32.8 L (33.4-35.9 G/DL), RDW 17.0 H (11.5-14.5 %), metamyelocyte 1 H (0 %), atypical lymph 6 H (0-5 %), sed rate 44 H (0-20 MM/HR), mononucleosis test positive (negative), mumps viral AB 4.70 (>= 1.10 positive: IgG antibody to mumps detected which may indicate current or previous exposure/immunization to mumps), mumps IgM antibody 4.74 (greater than 1.20 index: positive). At the time of the report, the patient recovered on an unspecified date. Follow-up information was received from a medical assistant (M.A.) in the physician's office via phone call. The M.A. confirmed that the patient was not hospitalized from 20-FEB-2008 to 25-FEB-2008. Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Red cell distribution width increased
Clinical narrative: Information has been received from a physician concerning a female patient with an "autoimmune disease" who on an unspecified date was vaccinated with MMR II. Subsequently, "last winter" in approximately 2007 the patient developed mumps after receiving the vaccination. Medical attention was sought. The patient was seen by the physician. It was unspecified if lab studies were performed. At the time of report the patient recovered on an unspecified date. There was no product quality complaint involved. Follow-up information has been received from a registered nurse and medical records dated 20-FEB-2008 concerning a 14 year old white female patient with colitis ulcerative who on 05-JAN-1998 was vaccinated S.Q. with a second dose of MMR II (lot # 622896/0740E). In February 2008, the patient developed acute mumps parotitis. Medical attention was sought. On 20-FEB-2008 the patient had lab studies performed which revealed the following abnormal results: albumin 3.3 L (3.4-5.0 G/DL), MCHC 32.8 L (33.4-35.9 G/DL), RDW 17.0 H (11.5-14.5 %), metamyelocyte 1 H (0 %), atypical lymph 6 H (0-5 %), sed rate 44 H (0-20 MM/HR), mononucleosis test positive (negative), mumps viral AB 4.70 (>= 1.10 positive: IgG antibody to mumps detected which may indicate current or previous exposure/immunization to mumps), mumps IgM antibody 4.74 (greater than 1.20 index: positive). At the time of the report, the patient recovered on an unspecified date. Follow-up information was received from a medical assistant (M.A.) in the physician's office via phone call. The M.A. confirmed that the patient was not hospitalized from 20-FEB-2008 to 25-FEB-2008. Additional information is not expected.
Age: 50.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Biopsy, Blister, Contusion, Mumps antibody test positive, Pruritus
Clinical narrative: Information has been received from a registered nurse concerning a 50 year old female employee with penicillin and codeine allergies and an unspecified medical history who on 06-JUN-2008 was vaccinated SQ with the first dose of MMR II (lot # 658516/0215X). Concomitant vaccinations on the same day included a first IM dose of ADACEL (lot # C2767AA) and a first ID dose of APLISOL (lot # 62412) (also reported as being administered on 03-JUN-2008). Concomitant medication included PLAQUENIL. On 11-JUN-2008 the employee was seen for a second "TST". Subsequently, "1.5 days after vaccination" on approximately 08-JUN-2008, the patient developed blisters starting on her legs and later on one arm. The patient broke out on her legs and arms with tiny blisters that became a large quarter-size rash. The patient was seen in the ER and was given steroids and a referral to a dermatologist. The dermatologist was unable to provide a diagnosis. The patient was recently seen by the nurse who described smooth areas the size of a quarter that looked like bruised areas on her legs. The patient was told that she had been in the sun too long. However, the patient had not been outside. The patient was referred to a dermatologist. By the time the patient got her appointment, the rash was flat and there was nothing to biopsy. The dermatologist did not give her a diagnosis. There was no rash on the patient legs, but her legs were marked with areas that were round, quarter-size and at a glance appeared to be bruised, but they were not. The patient felt they were scarred, but they did not appear to be. On 08-JUN-2008 the patient had a mumps titer drawn. The results were positive. At the time of the report, the patient recovered on an unspecified date. It was noted that the patient's legs were rash free, but there were still some faint "shadowing" where the spots were. Follow-up information has been received from a registered nurse concerning this 50 year old female employee with the same blistery rash, some in circular form came to the reporter's office. The patient stated she had been off for seven days, came back to work and on the second night started to itch and it then developed into a rash. The reporter encouraged her to go straight to the dermatologist that she had seen the last time this had happened. The patient did and the doctor was able to take a biopsy of the blisters. The dermatologist also told the patient it was not contagious, and felt it could be viral in nature. The reporter indicated it was not related to MMR II. No further information is available. This is in follow-up report(s) previously submitted on 5/29/2009. Follow-up information has been received from a registered nurse who saw the employee on 19-JUN-2009. The nurse stated they felt the patient's reaction was caused by Gain Detergent. The patient's sister had recently moved in and washed some their cloths together. After the practice was stopped, there was no more rash. No further information is available.
Age: 50.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a 50 year old female employee with penicillin and codeine allergies and an unspecified medical history who on 06-JUN-2008 was vaccinated SQ with the first dose of MMR II (lot # 658516/0215X). Concomitant vaccinations on the same day included a first IM dose of ADACEL (lot # C2767AA) and a first ID dose of APLISOL (lot # 62412) (also reported as being administered on 03-JUN-2008). Concomitant medication included PLAQUENIL. On 11-JUN-2008 the employee was seen for a second "TST". Subsequently, "1.5 days after vaccination" on approximately 08-JUN-2008, the patient developed blisters starting on her legs and later on one arm. The patient broke out on her legs and arms with tiny blisters that became a large quarter-size rash. The patient was seen in the ER and was given steroids and a referral to a dermatologist. The dermatologist was unable to provide a diagnosis. The patient was recently seen by the nurse who described smooth areas the size of a quarter that looked like bruised areas on her legs. The patient was told that she had been in the sun too long. However, the patient had not been outside. The patient was referred to a dermatologist. By the time the patient got her appointment, the rash was flat and there was nothing to biopsy. The dermatologist did not give her a diagnosis. There was no rash on the patient legs, but her legs were marked with areas that were round, quarter-size and at a glance appeared to be bruised, but they were not. The patient felt they were scarred, but they did not appear to be. On 08-JUN-2008 the patient had a mumps titer drawn. The results were positive. At the time of the report, the patient recovered on an unspecified date. It was noted that the patient's legs were rash free, but there were still some faint "shadowing" where the spots were. Follow-up information has been received from a registered nurse concerning this 50 year old female employee with the same blistery rash, some in circular form came to the reporter's office. The patient stated she had been off for seven days, came back to work and on the second night started to itch and it then developed into a rash. The reporter encouraged her to go straight to the dermatologist that she had seen the last time this had happened. The patient did and the doctor was able to take a biopsy of the blisters. The dermatologist also told the patient it was not contagious, and felt it could be viral in nature. The reporter indicated it was not related to MMR II. No further information is available. This is in follow-up report(s) previously submitted on 5/29/2009. Follow-up information has been received from a registered nurse who saw the employee on 19-JUN-2009. The nurse stated they felt the patient's reaction was caused by Gain Detergent. The patient's sister had recently moved in and washed some their cloths together. After the practice was stopped, there was no more rash. No further information is available.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: Information has been received from a physician concerning a 15 month old male patient who in approximately July 2003, was vaccinated with a first dose of MMR II. Subsequently, in approximately JUL-2003, the patient experienced a systemic rash located all over their body. The patient fully recovered. No product quality complaint was involved. Additional information has been requested.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 42 year old female patient who on an unspecified date was vaccinated with MMR II. It was noted that on an unspecified date the patient had a negative rubella titer. The patient's vaccination history was unknown. Medical attention was sought in the office. At the time of the report, the patient's status was unknown. There was no product quality complaint involved. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test positive, No therapeutic response, Rubella antibody positive
Clinical narrative: Information has been received from a medical assistant concerning a female who (on an unreported date) was vaccinated with MMR II (Lot # not reported). It was reported that the patient had a negative titer for the measles (date not reported), but that she was able to seroconvert rubella and mumps from a MMR II that was received in the past (date not reported). The patient had no symptoms. There was no product quality complaint. Additional information has been received from the medical assistant who, on 21-AUG-2008, reported that the patient failed to seroconvert for measles after two doses of MMR II. The first dose was administered at 1 year of age and the second at 10 years of age. Lot numbers unknown. Titers were performed "about 1 month ago". Medical attention was sought as the patient had an office visit. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a licensed practical nurse concerning a male patient with no known allergies or pertinent medical history who on an unspecified date was vaccinated IM with a first dose of 0.5ml of MMR II (lot # 657630/1483U). There was no concomitant medication. Subsequently, the patient had a negative rubella antibody titer on an unspecified date. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a pharmacist concerning a patient who received her primary series received a third dose of MMR II about four years ago because of insufficient mumps antibodies. The patient was given a titer after the last dose (time unspecified) and is "non-reactive" to the mumps. Unspecified medical attention was sought. No product quality complaint. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Rash maculo-papular, Rash pruritic, Urticaria
Clinical narrative: Initial and follow-up information has been received from a physician concerning a 4 year old female patient with a protease sensitivity and no pertinent medical history who on 23-JUL-2008 was vaccinated SC with a 0.5 mL first dose of MMR II (Lot# 656616/0871U [rHA] or 613567/0871B [HSA]). There was no concomitant medication. The day after receiving the vaccination, on 24-JUL-2008, the patient developed a rash. The maculopapular rash was confluent in the shape of a triangle, 3 X 4 cm in size, and was limited to the left upper quadrant of the abdomen. The rash was slightly itchy. The patient also developed a few hives on her face. The patient was evaluated in the office on 24-JUL-2008 and was prescribed topical hydrocortisone cream. No diagnostic laboratory tests were performed. The patient was evaluated by an unspecified dermatologist but details were not available. No further information was available. No product quality complaint was involved. In follow-up, the physician reported that 24 hours after vaccination on 24-JUL-2008, the patient developed a rash on left to right side. The patient was itchy. Then the patient developed hives on her face. After approximately 29-JUL-2008, the patient recovered. The physician doubted that the events were related to MMR II. It was reported that the patient's mother questioned if protease was in the vaccine. Patient was seen by a dermatologist. It was noted the patient had no illness at the time of the vaccination and no adverse events following prior vaccinations. Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a CMA and physician's assistant concerning a 38 year old female smoker with hypertension, penicillin allergy, condyloma and fibromyalgia and a history of cervical dysplasia with conization who in approximately July 2008, was vaccinated with MMR II (HSA) (Lot # 657118/0865U). Concomitant therapy included lisinopril and hydrochlorothiazide. The patient received her first dose of MMR II as a child in the 1970's. A titer for MMR II in June 2008 showed immunity to rubella, but not mumps or measles. The patient was revaccinated with 0.5 ml of IM MMR II (HSA) (Lot # 657118/0865U) (date not reported) and a titer was again done on 25-JUL-2008. This titer again showed no immunity to measles. Medical attention was sought as the patient was seen in the office. The patient was considered to be not recovered. There was no product quality complaint. Additional information was received on 29-SEP-2008 from the physician's assistant who indicated that on 10-JUN-2008, the patient's rubella antibodies were 71 (immune), rubeola (Measles) antibodies were <0.91 (negative) and mumps antibodies were <0.91 (negative). The patient was vaccinated on 17-JUN-2008 with her second dose of MMR II (Expiration date 30-MAY-2009). On 25-JUL-2008, the patient's rubella antibodies were >400 (immune), rubeola (Measles) antibodies were <0.91 (negative) and mumps antibodies were 1.86H (positive). The patient was still not rubeola (measles) immune after second dose of MMR II. No further information is expected.
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a pharmacist concerning a pregnant female who is "due any day now" that was vaccinated with MMR II and is testing low for her mumps titer. The pharmacist did not have any patient information and is not sure if the patient has received one or two doses of MMR II. The patient's present status is reported as low mumps titer. No product quality complaint. Additional information has been requested.
Sex: F
Vaccine: MMR, YF
Symptoms: Body temperature increased, Chest X-ray normal, Cough, Dizziness, Dyspnoea
Clinical narrative: Information has been received from a physician concerning a female patient in her "mid 40's" with no allergies or pertinent medical history who on 07-JUL-2008 was vaccinated SC with a 0.5 mL first dose of MMR II (lot# not reported). There was no concomitant medication. On 19-JUL-2008, the patient experienced a fever of 103 degrees F, nausea and dizziness. The patient was examined in the office. A complete blood count was normal and the results of a chest xray, ordered on 28-JUL-2008, were pending. The patient's fever, nausea, and dizziness persisted. No further information is available. No product quality complaint was involved. Follow up information was received from the doctor who reported the patient was vaccinated with MMR II and yellow fever vaccine  on 07-JUL-2008. The patient was seen on 25-JUL-2008 and 28-JUL-2008. The patient experienced a fever (T 102), diaphoresis and fatigue, then heart racing, some shortness of breath, and cough. It was reported that the patient's vial signs were stable and the patient was afebrile. On 28-JUL-2008 the patient's chest x-ray was within normal limits. The outcome was not reported. Additional information is not expected.
Sex: F
Vaccine: MMR, YF
Symptoms: Fatigue, Full blood count normal, Hyperhidrosis, Nausea, Palpitations
Clinical narrative: Information has been received from a physician concerning a female patient in her "mid 40's" with no allergies or pertinent medical history who on 07-JUL-2008 was vaccinated SC with a 0.5 mL first dose of MMR II (lot# not reported). There was no concomitant medication. On 19-JUL-2008, the patient experienced a fever of 103 degrees F, nausea and dizziness. The patient was examined in the office. A complete blood count was normal and the results of a chest xray, ordered on 28-JUL-2008, were pending. The patient's fever, nausea, and dizziness persisted. No further information is available. No product quality complaint was involved. Follow up information was received from the doctor who reported the patient was vaccinated with MMR II and yellow fever vaccine  on 07-JUL-2008. The patient was seen on 25-JUL-2008 and 28-JUL-2008. The patient experienced a fever (T 102), diaphoresis and fatigue, then heart racing, some shortness of breath, and cough. It was reported that the patient's vial signs were stable and the patient was afebrile. On 28-JUL-2008 the patient's chest x-ray was within normal limits. The outcome was not reported. Additional information is not expected.
Sex: F
Vaccine: MMR, YF
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a female patient in her "mid 40's" with no allergies or pertinent medical history who on 07-JUL-2008 was vaccinated SC with a 0.5 mL first dose of MMR II (lot# not reported). There was no concomitant medication. On 19-JUL-2008, the patient experienced a fever of 103 degrees F, nausea and dizziness. The patient was examined in the office. A complete blood count was normal and the results of a chest xray, ordered on 28-JUL-2008, were pending. The patient's fever, nausea, and dizziness persisted. No further information is available. No product quality complaint was involved. Follow up information was received from the doctor who reported the patient was vaccinated with MMR II and yellow fever vaccine  on 07-JUL-2008. The patient was seen on 25-JUL-2008 and 28-JUL-2008. The patient experienced a fever (T 102), diaphoresis and fatigue, then heart racing, some shortness of breath, and cough. It was reported that the patient's vial signs were stable and the patient was afebrile. On 28-JUL-2008 the patient's chest x-ray was within normal limits. The outcome was not reported. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody positive, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a consumer concerning his adult wife, who was undergoing fertility treatments, whom he believes was vaccinated as a child with MMR II (lot# not reported). The patient had a low titer for mumps during a recent OB/GYN genetic workup. He noted that her rubella and measles titers were normal. The patient sought medical attention at the office. The patient's outcome was not known. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a physician concerning a female who has negative titers for Rubella after she was already given 2 doses of MMR II during childhood. The patient is now looking to become a health care professional and so the office performed titers. No product quality complaint. Additional information has been received from a nurse indicating that after speaking with the physician, it was realized that they had no records concerning this patient or their reaction to MMR II in their office. The physician states that a medical center was involved with this during an emergency room visit. Additional information has been requested.
Age: 33.0
Sex: M
Vaccine: MMR
Symptoms: Incorrect route of drug administration, Injection site pain, Wrong technique in drug usage process
Clinical narrative: Information has been received from a physician concerning a 33 year old male, affiliated with another unspecified practice, who on 29-JUL-2008 was vaccinated IM in the upper arm with the second dose (lot# not reported). Per the physician, the patient was inadvertently administered a dose of MMR II diluted with MENACTRA. The patient now notices soreness at the injection site. No further information was available. Patient outcome was not reported. Additional information is not expected.
Age: 46.0
Sex: F
Vaccine: MMR
Symptoms: Incorrect route of drug administration, Oropharyngeal pain
Clinical narrative: Information has been received from a pharmacist concerning a 46 year old female who on approximately 19-JUL-2008, "about 3 weeks ago" was vaccinated 0.5mL, IM with MMR II (lot# not reported). It was reported that shortly after the patient's vaccination the patient developed a sore throat. The symptom has continued to the present. The patient has been treated with Amoxicillin. The patient sought unspecified medical attention in her doctor's office. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 5 year old male patient with congenital heart disease who was vaccinated at an unspecified time with MMR II (lot# not provided). Subsequently the patient developed an unspecified reaction that was described as greater than a mild fever. Subsequently, the patient recovered. Additional information has been requested.
Age: 55.0
Sex: F
Vaccine: MMR
Symptoms: Fatigue, Leukopenia, Nausea, Pain, Pain in jaw
Clinical narrative: Information has been received from a physician concerning a 55 year old female with a history of breast cancer who on approximately 29-JUL-2008 was vaccinated subsequently with a dose of MMR II (lot# not reported). On approximately 07-AUG-2008 the patient experienced generalized aches, fatigue, discomfort in her jaw, fever of 103f, nausea and vomiting. On 09-AUG-2008 the patient experienced rash on her face, chest and extremities and transient leukopenia. The patient's generalized aches, fatigue, discomfort in her jaw, fever of 103f, nausea, vomiting, rash on her face, chest and extremities and transient leukopenia persisted. In May 2008 the patient's white blood cell count was 5000, on 08-AUG-2008 it was 2000 and on 12-AUG-2008 it was back to 5500. Additional information has been requested.
Age: 55.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash generalised, Vomiting, White blood cell count decreased
Clinical narrative: Information has been received from a physician concerning a 55 year old female with a history of breast cancer who on approximately 29-JUL-2008 was vaccinated subsequently with a dose of MMR II (lot# not reported). On approximately 07-AUG-2008 the patient experienced generalized aches, fatigue, discomfort in her jaw, fever of 103f, nausea and vomiting. On 09-AUG-2008 the patient experienced rash on her face, chest and extremities and transient leukopenia. The patient's generalized aches, fatigue, discomfort in her jaw, fever of 103f, nausea, vomiting, rash on her face, chest and extremities and transient leukopenia persisted. In May 2008 the patient's white blood cell count was 5000, on 08-AUG-2008 it was 2000 and on 12-AUG-2008 it was back to 5500. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Abnormal behaviour
Clinical narrative: Information has been received from a healthcare worker concerning a 1 year old female who, on 06-JUL-2008, was vaccinated with MMR II (lot number: 660207/0453X). Patient's mother stated that after receiving the vaccination the patient seemed "different" and was doing things that seemed odd. The mother did not provide anymore details or examples of what she meant by the odd and different behavior. The physician has requested a lot check. A lot check has been requested. Lot check result for 660207/0453X: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the center and was released. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a certified medical assistant concerning a 22 year old male who on an unspecified date was vaccinated with a first dose of MMR (lot # not reported) an on 18-NOV-1997 was vaccinated with a second dose of MMR (lot#622262/0594E). On 01-JUL-2008 the patient had titers taken for measles and was non-reactive to measles vaccine. The patient sought unspecified medical attention. No other detail was available. The patient experienced another adverse event reported in WAES #0807USA05142. Additional information has been requested.
Age: 45.0
Sex: M
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning a 45 year old male who on 31-JUL-2008 was vaccinated SQ with the first dose of MMR (657357/1670U). On 03-AUG-2008 the patient experienced a rash that began on the patient's ankles and moved up his body to his neck. No further information was reported. It was reported that the patient was recovering. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/29/2009.  Information has been received from a registered nurse concerning a 45 year old male who on 31-JUL-2008 was vaccinated with the first 0.5 ml dose of MMR II (lot number 657357/1670U) subcutaneously.  There were no drug reactions, allergies, other medical history and concomitant medication.  On 03-AUG-2008, after receiving the MMR II, the patient experienced a rash, which began on patient's ankles and moved up his body to his neck.  The patient had sought medical attention by calling the practice.  No lab diagnostics study was performed.  At the time of report, the patient was recovering.  Follow-up information received from a registered nurse indicated that on 31-JUL-2008, at 13:00, a male patient was vaccinated with a first dose of MMR II.  The patient recovered on unspecifed date.  No further information is available.
Age: 4.0
Sex: F
Vaccine: IPV, MMR, TDAP, VARCEL
Symptoms: Swelling face
Clinical narrative: Information has been received from a physician concerning a 4 year old female with no medical history who, in 2004, was vaccinated with a first dose of MMR II and on 23-JUL-2008 was vaccinated with a second dose of MMR II (lot number: 659705/0356X). Suspect vaccination included a dose of VARIVAX (Merck). Other concomitant therapy included a dose of IPOL and a dose of Tdap. On 31-JUL-2008, the patient experienced front right facial swelling that was mumps-like. The patient was treated with antibiotics. The patient was seen by a dentist and the swelling was not related to her teeth. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Allergy to vaccine, Antibody test negative
Clinical narrative: Information has been received from a pharmacist concerning a "post menopausal" female volunteer at her facility who was vaccinated as a child with her first dose of MMR II (lot# not reported) and currently has negative titers. Also the patient had an allergic reaction to the first dose of MMR II. She may have received a partial dose of the vaccine sometime after the initial dose, but she does not remember the details. Her outcome was not reported. Additional information has been received from a pharmacist stating that she is not even sure that the patient had a reaction to MMR II. She states the patient "had a reaction to a childhood vaccine, but is not certain that is was MMR II. Furthermore it is also not certain that the patient was ever given MMR II". Additional information received from a pharmacist indicating that the patient had no previous records of having a vaccine, only remembers "a shot and my parents saying I was allergic". It was reported that she had no titers. Additional information is not expected.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Measles post vaccine, Rash papular, Scar
Clinical narrative: Initial and follow up information has been received from a mother concerning her son with a history of premature birth who on 08-OCT-2007 was vaccinated with MMR II (lot# 654443/0952F) (dose not reported). Subsequently the patient developed measles within 10 days of receiving the vaccine all over the body (head to toe). The patient still has scars and little raised bumps on his skin on his back, belly, and upper legs 6 months after the vaccination. It was reported that the patient was recovering from the measles. The patient sought unspecified medical attention by calling the physician's office. The mother indicated that she had "heard of other children that developed measles following vaccination with M-M-R" but had no information on other cases. This is one of two reports from the same source. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Joint stiffness, Oedema peripheral, Pain, Rheumatoid arthritis
Clinical narrative: Information has been received from a female consumer with penicillin, naproxen and ezetimibe (MSD) allergies who "14 years ago" in 1994 was vaccinated with MMR II. Concomitant therapy included PENTASA, NEXIUM and ENJUVIA. The patient reported that once a year ever since she received the vaccine she develops rheumatoid arthritis symptoms which last sometimes for a day to a week. The patient said "these symptoms move through her body once a year like an allergic reaction." The patient stated this past weekend (on approximately 09-AUG-2008) she woke up and could not get out of bed. It was noted that every joint on the upper half of her body was stiff, her hands were swollen and the pain progressed as the day went on. Medical attention was sought in the ER. It was unspecified if lab studies were performed. The patient was not hospitalized. At the time of the report, the patient was recovering. There was no product quality complaint involved. Additional information has been requested. The patient also had an adverse event after receiving ezetimibe (MSD) (WAES # 0803USA02130).